NCT01033825: Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis |
|
|
| Completed | 3 | 310 | US | Ciclesonide HFA Nasal Aerosol 320 mcg, Ciclesonide HFA Nasal Aerosol 160 mcg, HFA Nasal Aerosol placebo, Ciclesonide Aqueous Nasal Spray 200 mcg, Omnaris, AQ Nasal Spray Placebo, Placebo plus Dexamethasone HFA, Decadron, Placebo AQ plus Dexamethasone 6 mg | Sunovion | Perennial Allergic Rhinitis | 05/10 | 05/10 | | |
